Priority Date: 30.04.12 (US 201261640397P)

COMPOSITIONS AND METHODS FOR -GLUCAN IMMUNOTHERAPY

  • Application ID: EP13784472
  • Status: The patent has been granted

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 51 - 200 employees
Company dna vossius and partner
operating since 1961
Headquarter in Munich and 3 offices
active in Legal Services and IP-related Communication Service

Specialization

This EP application has the IPC combination A01, A61, C07, and C12. We found, that Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB, Vereenigde Octrooibureaux NV (V.O.), Niizuma Wasner GmbH and 17 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 30.04.2012 - Priority Date (US 201261640397P)
  • 07.11.2013 - Publication A1 (WO2013165593)
  • 08.04.2015 - Publication A1 (EP2854530)
  • 03.01.2018 - Publication B1 (EP2854530)